Literature DB >> 11457589

Expression and function of glycine receptors in striatal cholinergic interneurons from rat and mouse.

O A Sergeeva1, H L Haas.   

Abstract

Although glycine receptors are widely expressed in the forebrain their function is obscure. We studied their activation by two possible endogenous ligands, glycine and taurine, and demonstrate a different expression pattern of glycine receptors in neostriatal cholinergic interneurons from two rodent species. Single-cell-reverse transcription-polymerase chain reaction analysis of glycine receptor-subunit expression was combined with whole-cell recordings from acutely isolated cholinergic interneurons. All cells expressed the alpha2-glycine receptor subunit, the majority (72%) in mice but none in young and aged rats expressed the alpha3-subunit. The beta-subunit expression was associated with both a higher efficacy and a higher potency of the partial agonist taurine. Cells expressing the alpha3-subunit displayed a slower desensitization of taurine responses than of glycine responses, in contrast to cells expressing the alpha2-, beta-subunits where desensitization time constants were similar. Glycine responses were reduced by preapplication of taurine; this effect was more pronounced in cells lacking the alpha3-subunit. We demonstrate interspecies differences and heterogeneity in expression and function of glycine receptors within the same neuronal population in the neostriatum.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11457589     DOI: 10.1016/s0306-4522(01)00130-0

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  28 in total

1.  GABAA-receptor modification in taurine transporter knockout mice causes striatal disinhibition.

Authors:  O A Sergeeva; W Fleischer; A N Chepkova; U Warskulat; D Häussinger; M Siebler; H L Haas
Journal:  J Physiol       Date:  2007-10-25       Impact factor: 5.182

Review 2.  Taurine interaction with neurotransmitter receptors in the CNS: an update.

Authors:  Jan Albrecht; Arne Schousboe
Journal:  Neurochem Res       Date:  2005-12       Impact factor: 3.996

3.  Guanidinoethyl sulphonate is a glycine receptor antagonist in striatum.

Authors:  Olga A Sergeeva; Aisa N Chepkova; Helmut L Haas
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

4.  Release of endogenous amino acids from the striatum from developing and adult mice in ischemia.

Authors:  Simo S Oja; Pirjo Saransaari
Journal:  Neurochem Res       Date:  2011-04-13       Impact factor: 3.996

5.  The role of protein kinase C and cyclic AMP in the ammonia-induced shift of the taurine uptake/efflux balance towards efflux in C6 cells.

Authors:  Magdalena Zielińska; Barbara Zabłocka; Anna Dybel; Jan Albrecht
Journal:  Neurochem Res       Date:  2005-03       Impact factor: 3.996

6.  Long-lasting enhancement of corticostriatal transmission by taurine: role of dopamine and acetylcholine.

Authors:  A N Chepkova; O A Sergeeva; H L Haas
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

7.  Brain derived neurotrophic factor and neurotrophic factor 3 modulate neurotransmitter receptor expressions on developing spiral ganglion neurons.

Authors:  W Sun; R J Salvi
Journal:  Neuroscience       Date:  2009-09-22       Impact factor: 3.590

8.  Taurine regulation of short term synaptic plasticity in fragile X mice.

Authors:  Abdeslem El Idrissi; Lorenz S Neuwirth; William L'Amoreaux
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

9.  Interstitial concentrations of amino acids in the rat striatum during global forebrain ischemia and potassium-evoked spreading depression.

Authors:  Svetlana Molchanova; Peeter Kööbi; Simo S Oja; Pirjo Saransaari
Journal:  Neurochem Res       Date:  2004-08       Impact factor: 3.996

10.  Localization of glycine receptors in the human forebrain, brainstem, and cervical spinal cord: an immunohistochemical review.

Authors:  Kristin Baer; Henry J Waldvogel; Richard L M Faull; Mark I Rees
Journal:  Front Mol Neurosci       Date:  2009-11-04       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.